Effects of Group‐Based CBT/ERP and ACT on Emotion Dysregulation, Sleep, Anxiety Sensitivity and Psychological Flexibility in Adults With OCD
Clinical Psychology & Psychotherapy · 2026-11 · 33 (6)
DOI: 10.1002/cpp.70358 ↗At a glance
Randomisierte kontrollierte Studie in Clinical Psychology & Psychotherapy, published online on 2026-11-08. Written by Sara Kerstine Kaya Nielsen and 9 co-authors. Institution: Department of Psychology, University of Copenhagen, Copenhagen, Denmark. Major MEDLINE topics: Obsessive-Compulsive Disorder, Cognitive Behavioral Therapy, Emotional Regulation, Psychotherapy, Group. 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lundbeck Foundation, Lundbeckfonden.
Abstract (original language)
Introduction
Cognitive behavioural therapy with exposure and response prevention (CBT/ERP) is the recommended first‐line psychological treatment for obsessive‐compulsive disorder (OCD). Acceptance and commitment therapy (ACT) has emerged as a promising alternative, yet treatment comparisons have primarily focused on symptom severity and even less is known about their effects on other domains. Study Aim We examined the effect of group‐based ACT and CBT/ERP on emotion regulation, anxiety sensitivity, insomnia and psychological flexibility in adults with OCD.
Methods
176 adults with OCD were randomized to CBT/ERP or ACT and assessed with the Difficulties in Emotion Regulation Scale (DERS), Sleep Condition Indicator (SCI), Anxiety Sensitivity Index‐Revised (ASI‐R) and Acceptance and Action Questionnaire for Obsessions and Compulsions (AAQ‐OC) at baseline, post‐treatment, 6‐month and 12‐month follow‐up and analysed with Mixed‐Model Repeated Measures (MMRM).
Results
Both treatments showed similar improvements in the four domains across timepoints.
Conclusions
In line with our hypotheses, our results indicated that ACT may be non‐inferior to CBT/ERP for all secondary outcomes. However, as the trial was powered for the primary outcome (symptom severity) rather than for these secondary measures, our findings should be interpreted as suggestive. Nonetheless, these findings add to the growing evidence that ACT may be considered a viable treatment for OCD.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
- Mental Health Services, Capital Region of Denmark, Copenhagen, Denmark.
- Department of Psychiatry and Biobehavioral Sciences David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Mental Health Services, Region Zealand, Slagelse, Denmark.
ORCID profiles: Sara Kerstine Kaya Nielsen, Mette Øllgaard Pedersen, Clas Winding, Signe Vangkilde, Milan Obaidi, Martin Balslev Jørgensen, Anne Christine Stuart
Funding
- Lundbeck Foundation
- Lundbeckfonden
Cite
APA
Nielsen, S. K. K., Pedersen, M. Ø., Winding, C., Wolitzky-Taylor, K., Vangkilde, S., Obaidi, M., Rosenberg, N., Hageman, I., Jørgensen, M. B., & Stuart, A. C. (2026). Effects of Group‐Based CBT/ERP and ACT on Emotion Dysregulation, Sleep, Anxiety Sensitivity and Psychological Flexibility in Adults With OCD. Clinical Psychology & Psychotherapy, 33(6). https://doi.org/10.1002/cpp.70358
Vancouver
Nielsen SKK, Pedersen MØ, Winding C, Wolitzky-Taylor K, Vangkilde S, Obaidi M, et al. Effects of Group‐Based CBT/ERP and ACT on Emotion Dysregulation, Sleep, Anxiety Sensitivity and Psychological Flexibility in Adults With OCD. Clinical Psychology & Psychotherapy. 2026;33(6). doi:10.1002/cpp.70358
BibTeX
@article{Nielsen2026,
author = {Nielsen, Sara Kerstine Kaya and Pedersen, Mette Øllgaard and Winding, Clas and Wolitzky-Taylor, Kate and Vangkilde, Signe and Obaidi, Milan and Rosenberg, Nicole and Hageman, Ida and Jørgensen, Martin Balslev and Stuart, Anne Christine},
title = {Effects of Group‐Based CBT/ERP and ACT on Emotion Dysregulation, Sleep, Anxiety Sensitivity and Psychological Flexibility in Adults With OCD},
journal = {Clinical Psychology & Psychotherapy},
year = {2026},
volume = {33},
number = {6},
doi = {10.1002/cpp.70358}
}
EUVIMED